⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL359013 | 1.00 | — | — | |
| SCHEMBL2941639 | 0.81 | PTGS1 (0.55) | — | |
| SCHEMBL456395 | 0.81 | PTGS1 (0.55) | — | |
| SCHEMBL2941633 | 0.81 | PTGS1 (0.55) | — | |
| SCHEMBL28547750 | 0.81 | PTGS1 (0.55) | — | |
| SCHEMBL30159759 | 0.80 | — | — | |
| SCHEMBL30393841 | 0.80 | — | — | |
| SCHEMBL31130601 | 0.79 | — | — | |
| SCHEMBL28440494 | 0.79 | — | — | |
| SCHEMBL30159653 | 0.77 | PTGS1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116519812-A | Application of biomarker in preparation of gestational diabetes diagnostic reagent | 杭州凯莱谱精准医疗检测技术有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-116519812-A | Application of biomarker in preparation of gestational diabetes diagnostic reagent | 杭州凯莱谱精准医疗检测技术有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20100305311-A1 | NANOPARTICLE FOR SEPARATING PEPTIDE, METHOD FOR PREPARING THE SAME, AND METHOD FOR SEPARATING PEPTIDE USING THE SAME, | KOREA UNIVERSITY INDUSTRIAL & ACADEMIC COLLABORATION FOUNDATION | 2010-12-02 | — | — | US | disclosed |
| WO-2009069959-A2 | A NANOPARTICLE FOR SEPARATING PEPTIDE, METHOD FOR PREPARING THE SAME, AND METHOD FOR SEPARATING PEPTIDE USING THE SAME | KOREA UNIVERSITY INDUSTRIAL & ACADEMIC COLLABORATION FOUNDATION (KR) | 2009-06-04 | — | — | WO | disclosed |
| US-6028066-A | FOR DELIVERING HIGHER CONCENTRATIONS OF BIOACTIVE AGENTS TO IMPROVE EFFICACY OF THE BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 2000-02-22 | — | — | US | disclosed |
| WO-1998050041-A1 | NOVEL PRODRUGS COMPRISING FLUORINATED AMPHIPHILES | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |